CVS is reportedly conducting a strategic review and weighing options for separating some of the company’s businesses.

Barclays upgraded CVS Health Corp (NYSE: CVS) shares to Overweight from Equal Weight, citing a promising outlook for the ...

A federal antitrust watchdog is already conducting an investigation into and has filed a lawsuit against huge pharmacy ...

A federal antitrust watchdog is conducting an investigation into, and has filed suit against, huge pharmacy middlemen. Two ...

CVS Health (CVS – Research Report) received a Buy rating and an $82.00 price target from Barclays analyst Andrew Mok CFA today. The ...

The Woonsocket, R.I.-based health care giant said it would cut more than 100 positions in January at its corporate office in ...

Apple (NASDAQ: AAPL) stock fell 0.5% after Jefferies said that latest indications suggest that demand for the iPhone 16 ...

Analysts upgraded shares of the healthcare company to Overweight from Equal Weight and raised their price target to $82.

The NRP Group, a vertically integrated, best-in-class developer, builder, and manager of multifamily housing, in partnership ...

Kim Halbauer, regional president of Fifth Third Bank Kentucky, has been elected as the 2025 chair of the Kentucky Chamber of ...